How a US biotech ban could catalyze Chinese health insurance reform

    The Trump administration is considering blocking US pharma companies from buying Chinese-developed drug candidates. Per the New York Times: “At the heart of the possible clampdown is a drafted executive order that threatens to cut off the pipeline of Chinese-invented experimental treatments.” “The prospect of the order…has set off furious behind-the-scenes lobbying efforts by two diametrically opposed groups — each

    Read it

    The AI Plus initiative – China’s blueprint for AI diffusion

    This note was originally published for subscribers of Trivium Tech Daily on August 27. It has been republished here with additional commentary and minor edits. On August 26, the State Council published a high-level directive on implementing the AI Plus policy initiative.  The directive is a big deal: It represents China’s most comprehensive blueprint yet for how it plans to

    Read it

    Seeking the next DeepSeek: What China’s generative AI registration data can tell us about China’s AI competitiveness

    Download data set (.xlsx) In the early months of 2025, Chinese AI startup DeepSeek caught global observers off guard by releasing a highly advanced large language model (LLM) that matched top-tier Western offerings in both performance and scale. DeepSeek’s sudden and unexpected rise has highlighted a lack of clear understanding of China's generative AI innovation landscape among investors, policymakers, and

    Read it

    China’s 2025 economic plan

    It’s already March, and yet this is my first weekly wrap of the year. Being honest, I’ve tried to dip my toe back in several times – but with things moving so quickly, it’s often felt too daunting to write a step-back piece on any given week of China-related developments. But key moves on the domestic macro-policy and trade war

    Read it

    Trivium’s Policy Influence Index: The top 20 advisors shaping Chinese economic strategy

    Trivium’s Policy Influence Index (PII) continuously tracks over 700 policy advisors, evaluating their relative influence on China’s macroeconomic and financial policy discourse. We regularly update the index as advisors rise in prominence or see their influence diminish. This latest edition of the PII features the 20 advisors we currently rank as the most influential. You can find an explanation of

    Read it

    China showcases its export control regime with new critical minerals curbs

    Chinese authorities are ramping up their use of export controls to hit back economically at the US – and they’re just getting started. The latest: On Monday, the Biden administration unveiled new updates to its export controls on sales of semiconductors and semiconductor equipment to China. The rules – released by the US Commerce Department’s Bureau of Industry and Security (BIS) –

    Read it